NZ212521A - Sulphonylurea derivatives and pharmaceutical compositions - Google Patents

Sulphonylurea derivatives and pharmaceutical compositions

Info

Publication number
NZ212521A
NZ212521A NZ212521A NZ21252185A NZ212521A NZ 212521 A NZ212521 A NZ 212521A NZ 212521 A NZ212521 A NZ 212521A NZ 21252185 A NZ21252185 A NZ 21252185A NZ 212521 A NZ212521 A NZ 212521A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
sulphonylurea derivatives
sulphonylurea
derivatives
pharmaceutical
Prior art date
Application number
NZ212521A
Other languages
English (en)
Inventor
R W Harper
G A Poore
B J Rieder
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ212521A publication Critical patent/NZ212521A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ212521A 1984-06-27 1985-06-24 Sulphonylurea derivatives and pharmaceutical compositions NZ212521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62528084A 1984-06-27 1984-06-27

Publications (1)

Publication Number Publication Date
NZ212521A true NZ212521A (en) 1989-02-24

Family

ID=24505356

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ212521A NZ212521A (en) 1984-06-27 1985-06-24 Sulphonylurea derivatives and pharmaceutical compositions

Country Status (19)

Country Link
US (1) US4845128A (enEXAMPLES)
EP (1) EP0166615B1 (enEXAMPLES)
JP (1) JPH0714881B2 (enEXAMPLES)
KR (1) KR870000741B1 (enEXAMPLES)
CN (1) CN1006548B (enEXAMPLES)
AR (1) AR240916A1 (enEXAMPLES)
AT (1) ATE89733T1 (enEXAMPLES)
AU (1) AU571706B2 (enEXAMPLES)
CA (1) CA1291163C (enEXAMPLES)
DE (1) DE3587359T2 (enEXAMPLES)
DK (1) DK288785A (enEXAMPLES)
ES (1) ES8604128A1 (enEXAMPLES)
GR (1) GR851538B (enEXAMPLES)
HU (1) HU197298B (enEXAMPLES)
IL (1) IL75616A0 (enEXAMPLES)
NZ (1) NZ212521A (enEXAMPLES)
PH (1) PH22825A (enEXAMPLES)
PT (1) PT80708B (enEXAMPLES)
ZA (1) ZA854744B (enEXAMPLES)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110830A (en) * 1984-06-27 1992-05-05 Eli Lilly And Company Benzenesulfonamides treatment of tumors susceptible to
US5260338A (en) * 1984-06-27 1993-11-09 Eli Lilly And Company Anti-tumor method and compounds
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5216026A (en) * 1990-07-17 1993-06-01 Eli Lilly And Company Antitumor compositions and methods of treatment
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
EP0493642A1 (en) * 1991-01-02 1992-07-08 Takeo Dr. Takayanagi Novel sulfonyl derivatives
US5254589A (en) * 1991-10-15 1993-10-19 Warner-Lambert Company Sulfonyl urea and carbamate ACAT inhibitors
US5262440A (en) * 1991-12-10 1993-11-16 Eli Lilly And Company Antitumor compositions and methods of treatment
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
US5234955A (en) * 1991-12-20 1993-08-10 Eli Lilly And Company Antitumor compositions and methods of treatment
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
US5387681A (en) * 1992-08-19 1995-02-07 Eli Lilly And Company Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and sulfonamides
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
JP3025860U (ja) * 1995-09-18 1996-06-25 将一 川▲崎▼ 野良猫回避板
CN1079096C (zh) * 1996-08-22 2002-02-13 同和药品工业株式会社 用作抗肿瘤剂的芳磺酰基咪唑啉酮衍生物
AU4799797A (en) * 1996-10-04 1998-04-24 Eli Lilly And Company Antitumor compositions and methods of treatment
WO1998014185A1 (en) * 1996-10-04 1998-04-09 Eli Lilly And Company Antitumor compositions and methods of treatment
US6174921B1 (en) 1997-10-02 2001-01-16 Eli Lilly And Company Antitumor compositions and methods of treatment
HRP20031000A2 (en) * 2001-06-06 2004-04-30 Lilly Co Eli Benzoylsulfonamides and sulfonylbenzamidines as antitumour agents
JP2005522495A (ja) * 2002-04-11 2005-07-28 カルボマー インク 新規な糖尿病イメージングプローブ
WO2011009059A2 (en) * 2009-07-17 2011-01-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of treating or preventing cancer
CN114761379A (zh) * 2019-11-28 2022-07-15 三菱化学株式会社 显色剂及热敏记录材料

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
US3097241A (en) * 1956-08-10 1963-07-09 Hoechst Ag Nu-cyclohexane-sulphonyl-n'-(beta-phenylethyl)-urea
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1159937B (de) * 1960-06-29 1963-12-27 Heyden Chem Fab Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
US4276290A (en) * 1977-10-10 1981-06-30 Rohm And Haas Company Phosphonoureide and phosphonothioureide anthelmintics
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
IT1161220B (it) * 1983-04-21 1987-03-18 Montedison Spa Diidro-benzofurano derivati ad attivita' erbicida
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0166615A2 (en) 1986-01-02
ES544526A0 (es) 1986-01-16
US4845128A (en) 1989-07-04
GR851538B (enEXAMPLES) 1985-11-25
CN1006548B (zh) 1990-01-24
DE3587359T2 (de) 1993-11-04
AR240916A1 (es) 1991-03-27
JPH0714881B2 (ja) 1995-02-22
KR860000253A (ko) 1986-01-27
DE3587359D1 (de) 1993-07-01
DK288785D0 (da) 1985-06-26
KR870000741B1 (ko) 1987-04-13
AR240916A2 (es) 1991-03-27
CA1291163C (en) 1991-10-22
PT80708B (pt) 1987-10-20
EP0166615B1 (en) 1993-05-26
ATE89733T1 (de) 1993-06-15
AU4419285A (en) 1986-01-02
ES8604128A1 (es) 1986-01-16
HUT38093A (en) 1986-04-28
EP0166615A3 (en) 1990-03-21
DK288785A (da) 1985-12-28
HU197298B (en) 1989-03-28
PT80708A (en) 1985-07-01
CN85104893A (zh) 1987-01-07
ZA854744B (en) 1987-02-25
JPS6118754A (ja) 1986-01-27
PH22825A (en) 1989-01-19
IL75616A0 (en) 1985-10-31
AU571706B2 (en) 1988-04-21

Similar Documents

Publication Publication Date Title
NZ213528A (en) Purine derivatives and pharmaceutical compositions
NZ212521A (en) Sulphonylurea derivatives and pharmaceutical compositions
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212415A (en) 2-benzimidazolyl 2-pyridylmethylsulphide derivatives and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ211822A (en) Phenethanolamine derivatives and pharmaceutical compositions
NZ213821A (en) Piperidine derivatives and pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
NZ212499A (en) Substituted benzamide derivatives and pharmaceutical compositions
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ214175A (en) Cholecalciferol derivatives and pharmaceutical compositions
NZ213798A (en) Guanine derivatives and pharmaceutical compositions
NZ212320A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
NZ213877A (en) Peptide-substituted heterocyclic derivatives and pharmaceutical compositions
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions